The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Tertiary lymphoid structures in cancer
Abstract
Tertiary lymphoid structures in cancer: Tertiary lymphoid structures (TLSs) are lymphoid formations that are found in nonlymphoid tissues. TLS can develop in inflamed tissues and are associated with chronic inflammatory disorders, autoimmunity, and cancer. In the setting of tumors, TLSs facilitate the influx of immune cells into the tumor site and have therefore attracted interest as a means of improving anticancer immunity and favorable treatment response in patients. Schumacher and Thommen review the biology of TLSs and outline recent advances in TLS research. They discuss how TLSs are detected and defined, the mechanism(s) of formation in cancer, and the potential of targeting TLSs for therapeutic benefit. —PNK
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609 · cited 1×
“A first, relatively straightforward refinement is the subdivision of T cells based on their location at the tumor border or in the tumor parenchyma (9).”
BackgroundType, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
B cells and tertiary lymphoid structures promote immunotherapy response
Helmink, B. A., Reddy, S. M., Gao, J., Zhang, S., Basar, R., Thakur, R., Yizhak, K., Sade-Feldman, M., Blando, J., Han, G., et al. (2020) · Nature · doi:10.1038/s41586-019-1922-8 · Cited by 2,731 · cited 5×
“Although a number of observations are consistentwith a model in which ICB affects TLS functionality (15, 136, 137), the evidence is still circumstantial.”
BackgroundResultInfluentialSelf-citationAdoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Cabrita, R., Lauss, M., Sanna, A., Donia, M., Skaarup Larsen, M., Mitra, S., Johansson, I., Phung, B., Harbst, K., Vallon-Christersson, J., et al. (2020) · Nature · doi:10.1038/s41586-019-1914-8 · Cited by 2,374
The immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263
Miller, B. C., Sen, D. R., Al Abosy, R., Bi, K., Virkud, Y. V., LaFleur, M. W., Yates, K. B., Lako, A., Felt, K., Naik, G. S., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0312-6 · Cited by 2,087
Pagès, F., Mlecnik, B., Marliot, F., Bindea, G., Ou, F.-S., Bifulco, C., Lugli, A., Zlobec, I., Rau, T. T., Berger, M. D., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30789-x · Cited by 2,075
B cells are associated with survival and immunotherapy response in sarcoma
Petitprez, F., de Reyniès, A., Keung, E. Z., Chen, T. W.-W., Sun, C.-M., Calderaro, J., Jeng, Y.-M., Hsiao, L.-P., Lacroix, L., Bougoüin, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1906-8 · Cited by 1,942
Tertiary lymphoid structures in the era of cancer immunotherapy
Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0144-6 · Cited by 1,884
Siddiqui, I., Schaeuble, K., Chennupati, V., Fuertes Marraco, S. A., Calderon-Copete, S., Pais Ferreira, D., Carmona, S. J., Scarpellino, L., Gfeller, D., Pradervand, S., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.021 · Cited by 1,679
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.009 · Cited by 1,329
Keren, L., Bosse, M., Marquez, D., Angoshtari, R., Jain, S., Varma, S., Yang, S.-R., Kurian, A., Van Valen, D., West, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.039 · Cited by 1,183
Thommen, D. S., Koelzer, V. H., Herzig, P., Roller, A., Trefny, M., Dimeloe, S., Kiialainen, A., Hanhart, J., Schill, C., Hess, C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0057-z · Cited by 1,161 · cited 15×
“With respect to the effect of conventional therapies on TLS formation, induction of TLSs has been observed after neoadjuvant chemotherapy in NSCLC (145) and hepatoblastoma related to APC mutations (146).”
BackgroundResultInfluentialCD4+ follicular helper T cell infiltration predicts breast cancer survival
Gu-Trantien, C., Loi, S., Garaud, S., Equeter, C., Libin, M., de Wind, A., Ravoet, M., Le Buanec, H., Sibille, C., Manfouo-Foutsop, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67428 · Cited by 1,070
Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Savas, P., Virassamy, B., Ye, C., Salim, A., Mintoff, C. P., Caramia, F., Salgado, R., Byrne, D. J., Teo, Z. L., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0078-7 · Cited by 992
Okabe, Y., & Medzhitov, R. (2014) · Cell · doi:10.1016/j.cell.2014.04.016 · Cited by 884
Azimi, F., Scolyer, R. A., Rumcheva, P., Moncrieff, M., Murali, R., McCarthy, S. W., Saw, R. P., & Thompson, J. F. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8539 · Cited by 856
Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833
Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity
Moyron-Quiroz, J. E., Rangel-Moreno, J., Kusser, K., Hartson, L., Sprague, F., Goodrich, S., Woodland, D. L., Lund, F. E., & Randall, T. D. (2004) · Nature Medicine · doi:10.1038/nm1091 · Cited by 821
Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
Allen, E., Jabouille, A., Rivera, L. B., Lodewijckx, I., Missiaen, R., Steri, V., Feyen, K., Tawney, J., Hanahan, D., Michael, I. P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aak9679 · Cited by 820
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Jansen, C. S., Prokhnevska, N., Master, V. A., Sanda, M. G., Carlisle, J. W., Bilen, M. A., Cardenas, M., Wilkinson, S., Lake, R., Sowalsky, A. G., et al. (2019) · Nature · doi:10.1038/s41586-019-1836-5 · Cited by 817
Lymphoid organ development: from ontogeny to neogenesis
Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006) · Nature Immunology · doi:10.1038/ni1330 · Cited by 776
Organogenesis of lymphoid tissues
Mebius, R. E. (2003) · Nature Reviews Immunology · doi:10.1038/nri1054 · Cited by 744
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis
McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H., & Miller, S. D. (2005) · Nature Medicine · doi:10.1038/nm1202 · Cited by 694
Goc, J., Germain, C., Vo-Bourgais, T. K. D., Lupo, A., Klein, C., Knockaert, S., de Chaisemartin, L., Ouakrim, H., Becht, E., Alifano, M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1342 · Cited by 677
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
Cillo, A. R., Kürten, C. H. L., Tabib, T., Qi, Z., Onkar, S., Wang, T., Liu, A., Duvvuri, U., Kim, S., Soose, R. J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2019.11.014 · Cited by 668
Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells
Kurtulus, S., Madi, A., Escobar, G., Klapholz, M., Nyman, J., Christian, E., Pawlak, M., Dionne, D., Xia, J., Rozenblatt-Rosen, O., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.014 · Cited by 636
B cells, plasma cells and antibody repertoires in the tumour microenvironment
Sharonov, G. V., Serebrovskaya, E. O., Yuzhakova, D. V., Britanova, O. V., & Chudakov, D. M. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0257-x · Cited by 627
Tertiary lymphoid structures in cancer and beyond
Dieu-Nosjean, M.-C., Goc, J., Giraldo, N. A., Sautès-Fridman, C., & Fridman, W. H. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.09.006 · Cited by 617
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shalapour, S., Font-Burgada, J., Di Caro, G., Zhong, Z., Sanchez-Lopez, E., Dhar, D., Willimsky, G., Ammirante, M., Strasner, A., Hansel, D. E., et al. (2015) · Nature · doi:10.1038/nature14395 · Cited by 611
Kroeger, D. R., Milne, K., & Nelson, B. H. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2762 · Cited by 610
New insights into the development of lymphoid tissues
van de Pavert, S. A., & Mebius, R. E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2832 · Cited by 604
Cottrell, T. R., Thompson, E. D., Forde, P. M., Stein, J. E., Duffield, A. S., Anagnostou, V., Rekhtman, N., Anders, R. A., Cuda, J. D., Illei, P. B., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy218 · Cited by 592
Luther, S. A., Bidgol, A., Hargreaves, D. C., Schmidt, A., Xu, Y., Paniyadi, J., Matloubian, M., & Cyster, J. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.424 · Cited by 584
Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma
Oliveira, G., Stromhaug, K., Klaeger, S., Kula, T., Frederick, D. T., Le, P. M., Forman, J., Huang, T., Li, S., Zhang, W., et al. (2021) · Nature · doi:10.1038/s41586-021-03704-y · Cited by 558
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Lutz, E. R., Wu, A. A., Bigelow, E., Sharma, R., Mo, G., Soares, K., Solt, S., Dorman, A., Wamwea, A., Yager, A., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0027 · Cited by 550
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Caushi, J. X., Zhang, J., Ji, Z., Vaghasia, A., Zhang, B., Hsiue, E. H.-C., Mog, B. J., Hou, W., Justesen, S., Blosser, R., et al. (2021) · Nature · doi:10.1038/s41586-021-03752-4 · Cited by 543
Joshi, N. S., Akama-Garren, E. H., Lu, Y., Lee, D.-Y., Chang, G. P., Li, A., DuPage, M., Tammela, T., Kerper, N. R., Farago, A. F., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.006 · Cited by 520
Giraldo, N. A., Becht, E., Pagès, F., Skliris, G., Verkarre, V., Vano, Y., Mejean, A., Saint-Aubert, N., Lacroix, L., Natario, I., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2926 · Cited by 507
Th17 Cells Induce Ectopic Lymphoid Follicles in Central Nervous System Tissue Inflammation
Peters, A., Pitcher, L. A., Sullivan, J. M., Mitsdoerffer, M., Acton, S. E., Franz, B., Wucherpfennig, K., Turley, S., Carroll, M. C., Sobel, R. A., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.10.015 · Cited by 480
Calderaro, J., Petitprez, F., Becht, E., Laurent, A., Hirsch, T. Z., Rousseau, B., Luciani, A., Amaddeo, G., Derman, J., Charpy, C., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.003 · Cited by 479
Hollern, D. P., Xu, N., Thennavan, A., Glodowski, C., Garcia-Recio, S., Mott, K. R., He, X., Garay, J. P., Carey-Ewend, K., Marron, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.028 · Cited by 478
Salomonsson, S., Jonsson, M. V., Skarstein, K., Brokstad, K. A., Hjelmström, P., Wahren‐Herlenius, M., & Jonsson, R. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11311 · Cited by 472
Luther, S. A., Lopez, T., Bai, W., Hanahan, D., & Cyster, J. G. (2000) · Immunity · doi:10.1016/s1074-7613(00)80199-5 · Cited by 468
Siliņa, K., Soltermann, A., Attar, F. M., Casanova, R., Uckeley, Z. M., Thut, H., Wandres, M., Isajevs, S., Cheng, P., Curioni-Fontecedro, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1987 · Cited by 448
The development of inducible bronchus-associated lymphoid tissue depends on IL-17
Rangel-Moreno, J., Carragher, D. M., de la Luz Garcia-Hernandez, M., Hwang, J. Y., Kusser, K., Hartson, L., Kolls, J. K., Khader, S. A., & Randall, T. D. (2011) · Nature Immunology · doi:10.1038/ni.2053 · Cited by 441
Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer
Wu, S. Z., Roden, D. L., Wang, C., Holliday, H., Harvey, K., Cazet, A. S., Murphy, K. J., Pereira, B., Al‐Eryani, G., Bartonicek, N., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104063 · Cited by 436
Coppola, D., Nebozhyn, M., Khalil, F., Dai, H., Yeatman, T., Loboda, A., & Mulé, J. J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.03.007 · Cited by 434
Finkin, S., Yuan, D., Stein, I., Taniguchi, K., Weber, A., Unger, K., Browning, J. L., Goossens, N., Nakagawa, S., Gunasekaran, G., et al. (2015) · Nature Immunology · doi:10.1038/ni.3290 · Cited by 433
Messina, J. L., Fenstermacher, D. A., Eschrich, S., Qu, X., Berglund, A. E., Lloyd, M. C., Schell, M. J., Sondak, V. K., Weber, J. S., & Mulé, J. J. (2012) · Scientific Reports · doi:10.1038/srep00765 · Cited by 426
Tertiary lymphoid structures, drivers of the anti‐tumor responses in human cancers
Dieu‐Nosjean, M., Giraldo, N. A., Kaplon, H., Germain, C., Fridman, W. H., & Sautès‐Fridman, C. (2016) · Immunological Reviews · doi:10.1111/imr.12405 · Cited by 417
Genta, R. M., Hamner, H. W., & Graham, D. Y. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90235-9 · Cited by 409
van Dijk, N., Gil-Jimenez, A., Silina, K., Hendricksen, K., Smit, L. A., de Feijter, J. M., van Montfoort, M. L., van Rooijen, C., Peters, D., Broeks, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1085-z · Cited by 404
Self-citationTertiary lymphoid organs in infection and autoimmunity
Neyt, K., Perros, F., GeurtsvanKessel, C. H., Hammad, H., & Lambrecht, B. N. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.04.006 · Cited by 389
Di Caro, G., Bergomas, F., Grizzi, F., Doni, A., Bianchi, P., Malesci, A., Laghi, L., Allavena, P., Mantovani, A., & Marchesi, F. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2590 · Cited by 386
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
Posch, F., Silina, K., Leibl, S., Mündlein, A., Moch, H., Siebenhüner, A., Samaras, P., Riedl, J., Stotz, M., Szkandera, J., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1378844 · Cited by 380
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer
Voabil, P., de Bruijn, M., Roelofsen, L. M., Hendriks, S. H., Brokamp, S., van den Braber, M., Broeks, A., Sanders, J., Herzig, P., Zippelius, A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01398-3 · Cited by 380
Self-citationSautès-Fridman, C., Lawand, M., Giraldo, N. A., Kaplon, H., Germain, C., Fridman, W. H., & Dieu-Nosjean, M.-C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00407 · Cited by 379
GeurtsvanKessel, C. H., Willart, M. A. M., Bergen, I. M., van Rijt, L. S., Muskens, F., Elewaut, D., Osterhaus, A. D. M. E., Hendriks, R., Rimmelzwaan, G. F., & Lambrecht, B. N. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090410 · Cited by 376
Remark, R., Alifano, M., Cremer, I., Lupo, A., Dieu-Nosjean, M.-C., Riquet, M., Crozet, L., Ouakrim, H., Goc, J., Cazes, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3847 · Cited by 375
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
Griss, J., Bauer, W., Wagner, C., Simon, M., Chen, M., Grabmeier-Pfistershammer, K., Maurer-Granofszky, M., Roka, F., Penz, T., Bock, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12160-2 · Cited by 369
CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer
Gu-Trantien, C., Migliori, E., Buisseret, L., de Wind, A., Brohée, S., Garaud, S., Noël, G., Dang Chi, V. L., Lodewyckx, J.-N., Naveaux, C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91487 · Cited by 368
Hiraoka, N., Ino, Y., Yamazaki-Itoh, R., Kanai, Y., Kosuge, T., & Shimada, K. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.145 · Cited by 367
Development of Secondary Lymphoid Organs
Randall, T. D., Carragher, D. M., & Rangel-Moreno, J. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090257 · Cited by 339
de Chaisemartin, L., Goc, J., Damotte, D., Validire, P., Magdeleinat, P., Alifano, M., Cremer, I., Fridman, W.-H., Sautès-Fridman, C., & Dieu-Nosjean, M.-C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0952 · Cited by 338
Cimino-Mathews, A., Thompson, E., Taube, J. M., Ye, X., Lu, Y., Meeker, A., Xu, H., Sharma, R., Lecksell, K., Cornish, T. C., et al. (2016) · Human Pathology · doi:10.1016/j.humpath.2015.09.003 · Cited by 336
Johansson-Percival, A., He, B., Li, Z.-J., Kjellén, A., Russell, K., Li, J., Larma, I., & Ganss, R. (2017) · Nature Immunology · doi:10.1038/ni.3836 · Cited by 331
Gao, J., Navai, N., Alhalabi, O., Siefker-Radtke, A., Campbell, M. T., Tidwell, R. S., Guo, C. C., Kamat, A. M., Matin, S. F., Araujo, J. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1086-y · Cited by 318
Armengol, M. P., Juan, M., Lucas-Martín, A., Fernández-Figueras, M. T., Jaraquemada, D., Gallart, T., & Pujol-Borrell, R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61762-2 · Cited by 306
Halle, S., Dujardin, H. C., Bakocevic, N., Fleige, H., Danzer, H., Willenzon, S., Suezer, Y., Hämmerling, G., Garbi, N., Sutter, G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091472 · Cited by 295
NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures
Carrega, P., Loiacono, F., Di Carlo, E., Scaramuccia, A., Mora, M., Conte, R., Benelli, R., Spaggiari, G. M., Cantoni, C., Campana, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9280 · Cited by 271
Rodriguez, A. B., Peske, J. D., Woods, A. N., Leick, K. M., Mauldin, I. S., Meneveau, M. O., Young, S. J., Lindsay, R. S., Melssen, M. M., Cyranowski, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109422 · Cited by 271
Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence
Junt, T., Scandella, E., & Ludewig, B. (2008) · Nature Reviews Immunology · doi:10.1038/nri2414 · Cited by 267
Workel, H. H., Lubbers, J. M., Arnold, R., Prins, T. M., van der Vlies, P., de Lange, K., Bosse, T., van Gool, I. C., Eggink, F. A., Wouters, M. C. A., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0517 · Cited by 262
Persistence and Responsiveness of Immunologic Memory in the Absence of Secondary Lymphoid Organs
Moyron-Quiroz, J. E., Rangel-Moreno, J., Hartson, L., Kusser, K., Tighe, M. P., Klonowski, K. D., Lefrançois, L., Cauley, L. S., Harmsen, A. G., Lund, F. E., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.022 · Cited by 261
Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
Cipponi, A., Mercier, M., Seremet, T., Baurain, J.-F., Théate, I., van den Oord, J., Stas, M., Boon, T., Coulie, P. G., & van Baren, N. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1377 · Cited by 259
Bronchus-Associated Lymphoid Tissue (BALT)
Randall, T. D. (2010) · Advances in Immunology · doi:10.1016/b978-0-12-381300-8.00007-1 · Cited by 255
Maldonado, L., Teague, J. E., Morrow, M. P., Jotova, I., Wu, T. C., Wang, C., Desmarais, C., Boyer, J. D., Tycko, B., Robins, H. S., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007323 · Cited by 255
Lochner, M., Ohnmacht, C., Presley, L., Bruhns, P., Si-Tahar, M., Sawa, S., & Eberl, G. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100052 · Cited by 254
Overlapping Roles of CXCL13, Interleukin 7 Receptor α, and CCR7 Ligands in Lymph Node Development
Luther, S. A., Ansel, K. M., & Cyster, J. G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021294 · Cited by 252
Colbeck, E. J., Ager, A., Gallimore, A., & Jones, G. W. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01830 · Cited by 252
Yoshida, H., Naito, A., Inoue, J.-I., Satoh, M., Santee-Cooper, S. M., Ware, C. F., Togawa, A., Nishikawa, S., & Nishikawa, S.-I. (2002) · Immunity · doi:10.1016/s1074-7613(02)00479-x · Cited by 250
Stromal Cells in Chronic Inflammation and Tertiary Lymphoid Organ Formation
Buckley, C. D., Barone, F., Nayar, S., Bénézech, C., & Caamaño, J. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120252 · Cited by 249
Buisseret, L., Garaud, S., de Wind, A., Van den Eynden, G., Boisson, A., Solinas, C., Gu-Trantien, C., Naveaux, C., Lodewyckx, J.-N., Duvillier, H., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1257452 · Cited by 237
Rheumatic immune-related adverse events from cancer immunotherapy
Calabrese, L. H., Calabrese, C., & Cappelli, L. C. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0074-9 · Cited by 233
Tertiary lymphoid structures in cancer – considerations for patient prognosis
Munoz-Erazo, L., Rhodes, J. L., Marion, V. C., & Kemp, R. A. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0457-0 · Cited by 232
Montfort, A., Pearce, O., Maniati, E., Vincent, B. G., Bixby, L., Böhm, S., Dowe, T., Wilkes, E. H., Chakravarty, P., Thompson, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0081 · Cited by 231
Yang, M., Lu, J., Zhang, G., Wang, Y., He, M., Xu, Q., Xu, C., & Liu, H. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001136 · Cited by 229
Peske, J. D., Thompson, E. D., Gemta, L., Baylis, R. A., Fu, Y.-X., & Engelhard, V. H. (2015) · Nature Communications · doi:10.1038/ncomms8114 · Cited by 227
Hennequin, A., Derangère, V., Boidot, R., Apetoh, L., Vincent, J., Orry, D., Fraisse, J., Causeret, S., Martin, F., Arnould, L., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1054598 · Cited by 226
Pfannstiel, C., Strissel, P. L., Chiappinelli, K. B., Sikic, D., Wach, S., Wirtz, R. M., Wullweber, A., Taubert, H., Breyer, J., Otto, W., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0758 · Cited by 212
Fleige, H., Ravens, S., Moschovakis, G. L., Bölter, J., Willenzon, S., Sutter, G., Häussler, S., Kalinke, U., Prinz, I., & Förster, R. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131737 · Cited by 209
Lymphatic vessels and tertiary lymphoid organs
Ruddle, N. H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71611 · Cited by 202
Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation
Barone, F., Gardner, D. H., Nayar, S., Steinthal, N., Buckley, C. D., & Luther, S. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00477 · Cited by 194
Schrama, D., thor Straten, P., Fischer, W. H., McLellan, A. D., Bröcker, E.-B., Reisfeld, R. A., & Becker, J. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00094-2 · Cited by 192
Sims, G. P., Shiono, H., Willcox, N., & Stott, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1935 · Cited by 188
Rangel-Moreno, J., Moyron-Quiroz, J. E., Hartson, L., Kusser, K., & Randall, T. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700591104 · Cited by 182
Ager, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00045 · Cited by 179
Tertiary Lymphoid Structures: Diversity in Their Development, Composition, and Role
Gago da Graça, C., van Baarsen, L. G. M., & Mebius, R. E. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000873 · Cited by 178
Thaunat, O., Patey, N., Caligiuri, G., Gautreau, C., Mamani-Matsuda, M., Mekki, Y., Dieu-Nosjean, M.-C., Eberl, G., Ecochard, R., Michel, J.-B., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903589 · Cited by 174
Lee, Y., Chin, R. K., Christiansen, P., Sun, Y., Tumanov, A. V., Wang, J., Chervonsky, A. V., & Fu, Y.-X. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.016 · Cited by 174
Coronella, J. A., Spier, C., Welch, M., Trevor, K. T., Stopeck, A. T., Villar, H., & Hersh, E. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1829 · Cited by 171
Manzo, A., Bombardieri, M., Humby, F., & Pitzalis, C. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00861.x · Cited by 171
Intragraft Th17 Infiltrate Promotes Lymphoid Neogenesis and Hastens Clinical Chronic Rejection
Deteix, C., Attuil-Audenis, V., Duthey, A., Patey, N., McGregor, B., Dubois, V., Caligiuri, G., Graff-Dubois, S., Morelon, E., & Thaunat, O. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902999 · Cited by 170
New predictors for immunotherapy responses sharpen our view of the tumour microenvironment
Bruno, T. C. (2020) · Nature · doi:10.1038/d41586-019-03943-0 · Cited by 165
Increased lymphangiogenesis in joints of mice with inflammatory arthritis
Zhang, Q., Lu, Y., Proulx, S. T., Guo, R., Yao, Z., Schwarz, E. M., Boyce, B. F., & Xing, L. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2326 · Cited by 160
Nzula, S., Going, J. J., & Stott, D. I. (2003) · PubMed · Cited by 159
Prabhakaran, S., Rizk, V. T., Ma, Z., Cheng, C.-H., Berglund, A. E., Coppola, D., Khalil, F., Mulé, J. J., & Soliman, H. H. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0864-z · Cited by 150
Characteristics of tertiary lymphoid structures in primary cancers
Goc, J., Fridman, W. H., Sautès‐Fridman, C., & Dieu‐Nosjean, M. (2013) · OncoImmunology · doi:10.4161/onci.26836 · Cited by 149
T Cell Zone Resident Macrophages Silently Dispose of Apoptotic Cells in the Lymph Node
Baratin, M., Simon, L., Jorquera, A., Ghigo, C., Dembélé, D., Nowak, J., Gentek, R., Wienert, S., Klauschen, F., MALISSEN, B., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.019 · Cited by 139
Treg Depletion Licenses T Cell–Driven HEV Neogenesis and Promotes Tumor Destruction
Colbeck, E. J., Jones, E., Hindley, J. P., Smart, K., Schulz, R., Browne, M., Cutting, S., Williams, A. S., Parry, L., Godkin, A. J., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0131 · Cited by 138
Figenschau, S. L., Fismen, S., Fenton, K. A., Fenton, C. G., & Mortensen, E. (2015) · BMC Cancer · doi:10.1186/s12885-015-1116-1 · Cited by 136
Hindley, J. P., Jones, E., Smart, K., Bridgeman, H. M., Lauder, S. N., Ondondo, B., Cutting, S., Ladell, K., Wynn, K. K., Withers, D. R., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1912 · Cited by 129
Zhu, W., Germain, C., Liu, Z., Sebastian, Y., Devi-Marulkar, P., Knockaert, S., Brohawn, P. Z., Lehmann, K. P., Damotte, D., Validire, P., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1051922 · Cited by 125
Jézéquel, P., Kerdraon, O., Hondermarck, H., Guérin‐Charbonnel, C., Lasla, H., Gouraud, W., Canon, J.-L. R., Gombos, A., Dalenc, F., Delaloge, S., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1148-6 · Cited by 124
Liu, X., Tsang, J. Y., Hlaing, T., Hu, J., Ni, Y., Chan, S., Cheung, S. Y., & Tse, G. M.-K. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0029 · Cited by 115
Organogenesis of peripheral lymphoid organs
Nishikawa, S., Honda, K., Vieira, P., & Yoshida, H. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00063.x · Cited by 113
Lymphotoxin-alpha contributes to lymphangiogenesis
Mounzer, R. H., Svendsen, Ø. S., Bałuk, P., Bergman, C. M., Padera, T. P., Wiig, H., Jain, R. K., McDonald, D. M., & Ruddle, N. H. (2010) · Blood · doi:10.1182/blood-2009-12-256065 · Cited by 113
Tertiary Intratumor Lymphoid Tissue in Colo-Rectal Cancer
Bergomas, F., Grizzi, F., Doni, A., Pesce, S., Laghi, L., Allavena, P., Mantovani, A., & Marchesi, F. (2011) · Cancers · doi:10.3390/cancers4010001 · Cited by 109
Guedj, K., Khallou‐Laschet, J., Clément, M., Morvan, M., Gaston, A., Fornasa, G., Dai, J., Gervais, M., Eberl, G., Michel, J., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt263 · Cited by 96
Remark, R., Mansuet‐Lupo, A., Alifano, M., Biton, J., Ouakrim, H., Stefani, A. D., Cremer, I., Goc, J., Régnard, J., Dieu‐Nosjean, M., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1255394 · Cited by 92
The role of CD45+CD4+CD3– cells in lymphoid organ development
Cupedo, T., Kraal, G., & Mebius, R. E. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18905.x · Cited by 87
Tumor-infiltrating B cells and T cells
Nielsen, J. S., & Nelson, B. H. (2012) · OncoImmunology · doi:10.4161/onci.21650 · Cited by 85
APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures
Morcrette, G., Hirsch, T. Z., Badour, E., Pilet, J., Caruso, S., Caldéraro, J., Martin, Y., Imbeaud, S., Letouzé, É., Rebouissou, S., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1583547 · Cited by 85
Stranford, S. A., & Ruddle, N. H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00350 · Cited by 83
TNFα-dependent development of lymphoid tissue in the absence of RORγt+ lymphoid tissue inducer cells
Furtado, G. C., Pacer, M. E., Bongers, G., Bénézech, C., He, Z., Chen, L., Berin, M. C., Kollias, G. A., Caamaño, J., & Lira, S. A. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.79 · Cited by 79
Siliņa, K., Rulle, U., Kalniņa, Z., & Linē, A. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1544-9 · Cited by 76
Schlößer, H., Thelen, M., Lechner, A., Wennhold, K., Garcia-Marquez, M. A., Rothschild, S. I., Staib, E., Zander, T., Beutner, D., Gathof, B. S., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1512458 · Cited by 74
The Microenvironment of Germ Cell Tumors Harbors a Prominent Antigen-Driven Humoral Response
Willis, S. N., Mallozzi, S. S., Rodig, S. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803424 · Cited by 68
Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules
McMullen, T. P. W., Lai, R. L., Dabbagh, L., Wallace, T., & de Gara, C. J. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04147.x · Cited by 66
A new role for circulating T follicular helper cells in humoral response to anti-PD-1 therapy
Sánchez‐Alonso, S., Setti-Jerez, G., Arroyo, M., Hernández, T., Martos, M. I., Sánchez-Torres, J. M., Colomer, R., Ramiro, A. R., & Alfranca, A. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001187 · Cited by 66
Solinas, C., Marcoux, D., Garaud, S., Vitória, J. R., den Eynden, G. V., de Wind, A., Silva, P. D., Boisson, A., Craciun, L., Larsimont, D., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.027 · Cited by 64
Schrama, D., Voigt, H., Eggert, A. O., Xiang, R., Zhou, H., Schumacher, T. N., Andersen, M. H., Straten, P. T., Reisfeld, R. A., & Becker, J. C. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0352-x · Cited by 63
Self-citationRole of chemokines in the development of secondary and tertiary lymphoid tissues
Cupedo, T., & Mebius, R. E. (2003) · Seminars in Immunology · doi:10.1016/j.smim.2003.08.002 · Cited by 63
Alsughayyir, J., Pettigrew, G. J., & Motallebzadeh, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01639 · Cited by 61
FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer
Silva, P. D., Garaud, S., Solinas, C., de Wind, A., den Eyden, G. V., José, V., Gu‐Trantien, C., Migliori, E., Boisson, A., Naveaux, C., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.066 · Cited by 54
Guedj, K., Abitbol, Y., Cazals-Hatem, D. L., Morvan, M., Maggiori, L., Panis, Y. H., Bouhnik, Y., Caligiuri, G., Corcos, O., & Nicoletti, A. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.05.009 · Cited by 52
Kim, A., Lee, S. J., Ahn, J., Park, W. Y., Shin, D., Lee, C. H., Kwon, H., Jeong, Y. J., Ahn, H. Y., Hoseok, I., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224430 · Cited by 48
Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
Goc, J., Fridman, W. H., Hammond, S. A., Sautès‐Fridman, C., & Dieu‐Nosjean, M. (2014) · OncoImmunology · doi:10.4161/onci.28976 · Cited by 46
TNFΔARE Mice Display Abnormal Lymphatics and Develop Tertiary Lymphoid Organs in the Mesentery
Rehal, S., & von der Weid, P. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.12.007 · Cited by 46
Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors
Matsubara, S., Seki, M., Suzuki, S., Komori, T., & Takamori, M. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0736-4 · Cited by 30
Cited by
Kidney fibrosis: from mechanisms to therapeutic medicines
Huang, R., Fu, P., & Ma, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01379-7 · Cited by 781
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 682
Dynamics and specificities of T cells in cancer immunotherapy
Oliveira, G., & Wu, C. J. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00560-y · Cited by 525
Spatial profiling technologies illuminate the tumor microenvironment
Elhanani, O., Ben-Uri, R., & Keren, L. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.01.010 · Cited by 510
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Sherman, M. H., & Beatty, G. L. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031621-024600 · Cited by 467
Metadata
- Authors
- Schumacher, T. N., & Thommen, D. S.
- Venue
- Science
- Published
- 2022-01-07
- Volume
- 375
- Issue
- 6576
- Pages
- eabf9419-eabf9419
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4205511851
- Cited by
- 1,142
- References
- 147
- FWCI
- 79.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.